Groups Treatment/Dose (mg/mL) Glucose (mM) Insulin (μU/ml) Homeostatic insulin resistance index (HOMA‐IR)
 Normal Control 5.85±0.42 3.10± 0.11 0.82±0.09
Control + CAMBA (25mg/kg) 5.48±0.61  3.18± 0.27 0.79±0.05
Control +CAMBA (50mg/kg) 5.14± 0.34 3.33± 0.15 0.77± 0.03
Diabetic Control 21.52± 2.60** 1.67± 0.06** 1.63± 0.07**
Diabetic + CAMBA (25mg/kg) 8.15± 2.07** 2.03± 0.10**  0.75± 0.04*
 Diabetic + CAMBA (50mg/kg) 6.41±  0.59**  2.10±0.09** 0.61± 0.08**
Diabetic +Glibenclamide(5mg/kg) 5.36±0.59**  2.83±0.18** 0.69±0.06**
Values are given as mean ± SD for groups of eight animals each. Homeostatic index of insulin resistance HOMA-IR), calculated by glucose (mM) x insulin (µU/ml)/22.5. Values are statistically significant at *P<0.05 & **P<0.01. Diabetic control rats were compared with normal control rats. Experimental groups were compared with the diabetic control rats
Table 3: Effect of CAMBA on plasma glucose, insulin and HOMA‐IR in control and experimental groups of rats.